Periprosthetic Joint Infection in Patients With Inflammatory Arthritis: Optimal Tests to Differentiate From Flares.
Journal
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
ISSN: 1536-7355
Titre abrégé: J Clin Rheumatol
Pays: United States
ID NLM: 9518034
Informations de publication
Date de publication:
30 Oct 2024
30 Oct 2024
Historique:
medline:
30
10
2024
pubmed:
30
10
2024
entrez:
30
10
2024
Statut:
aheadofprint
Résumé
Diagnosis of periprosthetic joint infection (PJI) in patients with inflammatory arthritis (IA) is challenging, as features of IA flares can mimic infection. We aimed to cross-sectionally determine if the optimal tests to diagnose PJI in osteoarthritis were present in patients with IA flares. We enrolled patients from October 2020 to July 2022 in 3 groups: (a) PJI-total joint arthroplasty patients undergoing revision for infection, (b) IA Flare-IA patients with a flaring native joint, and (c) IA Aseptic-total joint arthroplasty patients with IA undergoing aseptic arthroplasty revision. We compared blood and synovial fluid markers between the cohorts using Kruskal-Wallis and Fisher exact tests to assess marker sensitivity and specificity. Of 52 cases overall, 40% had rheumatoid arthritis, 20% psoriatic arthritis, and 11% osteoarthritis (in PJI group). PJI cases had higher C-reactive protein (CRP) and synovial fluid polymorphonuclear neutrophil percentage (%PMN). Alpha-defensin tested positive in 93% of PJI cases, 20% of IA Flares, and 6% of IA Aseptic (p < 0.01). Synovial white blood cell count >3000/μL and positive alpha-defensin were highly sensitive (100%) in diagnosing infection; however, specificity was 50% for white blood cell counts and 79% for alpha-defensin. PJI diagnosis was nearly 5 times more likely with positive alpha-defensin and almost 6 times more likely with %PMNs >80. Blood markers interleukin-6, procalcitonin, and d-dimer were neither sensitive nor specific, whereas erythrocyte sedimentation rate and CRP showed 80% sensitivity, but 47% and 58% respective specificities. Although synovial %PMNs, CRP, and alpha-defensin are sensitive tests for diagnosing PJI, they are less specific and may be positive in IA flares.
Identifiants
pubmed: 39476402
doi: 10.1097/RHU.0000000000002157
pii: 00124743-990000000-00264
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Galloway J, Cope AP. The ying and yang of fever in rheumatic disease. Clin Med (Lond). 2015;15:288–291. doi:10.7861/clinmedicine.15-3-288.
doi: 10.7861/clinmedicine.15-3-288
Mabey E, Rutherford A, Galloway J. Differentiating disease flare from infection: a common problem in rheumatology. Do 18F-FDG PET/CT scans and novel biomarkers hold the answer. Curr Rheumatol Rep. 2018;20:70. doi:10.1007/s11926-018-0779-4.
doi: 10.1007/s11926-018-0779-4
Koh CK, Zeng I, Ravi S, et al. Periprosthetic joint infection is the main cause of failure for modern knee arthroplasty: an analysis of 11,134 knees. Clin Orthop Relat Res. 2017;475:2194–2201. doi:10.1007/s11999-017-5396-4.
doi: 10.1007/s11999-017-5396-4
Qiao Y, Li F, Zhang L, et al. A systematic review and meta-analysis comparing outcomes following total knee arthroplasty for rheumatoid arthritis versus for osteoarthritis. BMC Musculoskelet Disord. 2023;24:484. doi:10.1186/s12891-023-06601-9.
doi: 10.1186/s12891-023-06601-9
Van Duren BH, Wignall A, Goodman S, et al. The effect of perioperative biologic disease-modifying anti-rheumatic drugs on the risk of postoperative complications: surgical site infection, delayed wound healing, and disease flares following orthopaedic surgical procedures. J Bone Joint Surg Am. 2022;104:1116–1126. doi:10.2106/JBJS.21.00811.
doi: 10.2106/JBJS.21.00811
Poss R, Thornhill TS, Ewald FC, et al. Factors influencing the incidence and outcome of infection following total joint arthroplasty. Clin Orthop Relat Res. 1984;182:117–126.
George MD, Baker JF, Winthrop K, et al. Risk of biologics and glucocorticoids in patients with rheumatoid arthritis undergoing arthroplasty. Ann Intern Med. 2019;171:680. doi:10.7326/L19-0528.
doi: 10.7326/L19-0528
Shichman I, Ward SA, Lu L, et al. Failed 2-stage revision knee arthroplasty for periprosthetic joint infection—patient characteristics and outcomes. J Arthroplasty. 2023;38:2177–2182. doi:10.1016/j.arth.2023.04.063.
doi: 10.1016/j.arth.2023.04.063
Mirza SZ, Richardson SS, Kahlenberg CA, et al. Diagnosing prosthetic joint infections in patients with inflammatory arthritis: a systematic literature review. J Arthroplasty. 2019;34:1032–1036.e2. doi:10.1016/j.arth.2019.01.051.
doi: 10.1016/j.arth.2019.01.051
Qin L, Du C, Yang J, et al. Synovial fluid interleukin levels cannot distinguish between prosthetic joint infection and active rheumatoid arthritis after hip or knee arthroplasty. Diagnostics. 2022;12:1196. doi:10.3390/diagnostics12051196.
doi: 10.3390/diagnostics12051196
Parvizi J, Tan TL, Goswami K, et al. The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty. 2018;33:1309–1314.e2. doi:10.1016/j.arth.2018.02.078.
doi: 10.1016/j.arth.2018.02.078
Montoya-delaTorre C, Fernández-Valencia JA, Martínez-Pastor JC, et al. Usefulness of histology for predicting infection at the time of hip and knee revision in patients with rheumatoid arthritis. Arch Orthop Trauma Surg. 2021;142:2489–2495. doi:10.1007/s00402-021-03868-2.
doi: 10.1007/s00402-021-03868-2
Viswanathan VK, Sakthivelnathan V, Menedal A, et al. How does systemic lupus erythematosus impact the peri-operative complication rates in primary hip arthroplasty? A national inpatient sample-based study. Arch Orthop Trauma Surg. 2022;143:2209–2216. doi:10.1007/s00402-022-04475-5.
doi: 10.1007/s00402-022-04475-5
Li Z, Du Y, Xiang S, et al. Risk factors of perioperative complications and transfusion following total hip arthroplasty in systemic lupus erythematosus patients. Lupus. 2019;28:1134–1140. doi:10.1177/0961203319862609.
doi: 10.1177/0961203319862609
Cancienne JM, Werner BC, Browne JA. Complications of primary total knee arthroplasty among patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and osteoarthritis. J Am Acad Orthop Surg. 2016;24:567–574. doi:10.5435/JAAOS-D-15-00501.
doi: 10.5435/JAAOS-D-15-00501
Schnaser EA, Browne JA, Padgett DE, et al. Perioperative complications in patients with inflammatory arthropathy undergoing total hip arthroplasty. J Arthroplasty. 2016;31:2286–2290. doi:10.1016/j.arth.2016.03.023.
doi: 10.1016/j.arth.2016.03.023
Tarabichi M, Shohat N, Goswami K, et al. Diagnosis of periprosthetic joint infection: the potential of next-generation sequencing. J Bone Joint Surg. 2018;100:147–154. doi:10.2106/JBJS.17.00434.
doi: 10.2106/JBJS.17.00434
Berbari EF, Marculescu C, Sia I, et al. Culture-negative prosthetic joint infection. Clin Infect Dis. 2007;45:1113–1119. doi:10.1086/522184.
doi: 10.1086/522184
Sculco P, Kapadia M, Moezinia CJ, et al. Clinical and histological features of prosthetic joint infections may differ in patients with inflammatory arthritis and osteoarthritis. HSS J. 2023;19:146–153. doi:10.1177/15563316231153395.
doi: 10.1177/15563316231153395
Van Schaik TJA, De Jong LD, Van Meer MPA, et al. The concordance between preoperative synovial fluid culture and intraoperative tissue cultures in periprosthetic joint infection: a systematic review. J Bone Joint Infect. 2022;7:259–267. doi:10.5194/jbji-7-259-2022.
doi: 10.5194/jbji-7-259-2022
Vandenbroucke JP, Von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12:1500–1524. doi:10.1016/j.ijsu.2014.07.014.
doi: 10.1016/j.ijsu.2014.07.014
Parvizi J, Gehrke T. Definition of periprosthetic joint infection. J Arthroplasty. 2014;29:1331. doi:10.1016/j.arth.2014.03.009.
doi: 10.1016/j.arth.2014.03.009
Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from the workgroup of the MusculoSkeletal Infection Society. Clin Orthop Relat Res. 2011;469:2992–2994. doi:10.1007/s11999-011-2102-9.
doi: 10.1007/s11999-011-2102-9
Akgul O, Ozgocmen S. Classification criteria for spondyloarthropathies. World J Orthop. 2011;2:107. doi:10.5312/wjo.v2.i12.107.
doi: 10.5312/wjo.v2.i12.107
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid Arthritis Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62:2569–2581. doi:10.1002/art.27584.
doi: 10.1002/art.27584
Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324. doi:10.1002/art.1780310302.
doi: 10.1002/art.1780310302
Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665–2673. doi:10.1002/art.21972.
doi: 10.1002/art.21972
Vargas-Santos AB, Taylor WJ, Neogi T. Gout classification criteria: update and implications. Curr Rheumatol Rep. 2016;18:46. doi:10.1007/s11926-016-0594-8.
doi: 10.1007/s11926-016-0594-8
Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71:1400–1412. doi:10.1002/art.40930.
doi: 10.1002/art.40930
Kim SJ, Cho YJ. Current guideline for diagnosis of periprosthetic joint infection: a review article. Hip Pelvis. 2021;33:11–17. doi:10.5371/hp.2021.33.1.11.
doi: 10.5371/hp.2021.33.1.11
Vale JS, Castelo FS, Barros BS, et al. Synovial fluid biomarkers for the diagnosis of periprosthetic joint infection—a systematic review and meta-analysis of their diagnostic accuracy according to different definitions. J Arthroplasty. 2023;38:2731–2738.e3. doi:10.1016/j.arth.2023.06.017.
doi: 10.1016/j.arth.2023.06.017
Yu JS, Bornes TD, Youssef MP, et al. Which combination is the best? A comparison of the predictive potential of serum biomarker combinations to diagnose periprosthetic joint infection. J Arthroplasty. 2023;38:S381–S388. doi:10.1016/j.arth.2023.05.025.
doi: 10.1016/j.arth.2023.05.025
Böhler C, Weimann P, Alasti F, et al. Rheumatoid arthritis disease activity and the risk of aseptic arthroplasty loosening. Semin Arthritis Rheum. 2020;50:245–251. doi:10.1016/j.semarthrit.2019.07.011.
doi: 10.1016/j.semarthrit.2019.07.011